All patients
non invasive oxygen
anti-inflammatory therapies in COVID 19 hospitalized - Summary of results Outcome TE 95% CI n k I2 ROB Pub. bias death D28detailed results Lanzoni, 2021 0.14 [0.02; 0.96]
Shi, 2020 0.53 [0.01; 27.55]
0.18 [0.03 ; 1.02 ] Lanzoni, 2021, Shi, 2020 2 0% 124 moderate not evaluable death or transfer to ICUdetailed results COLCHIVID, 2021 0.83 [0.35; 1.95]
0.83 [0.35 ; 1.95 ] COLCHIVID, 2021 1 0% NA not evaluable deathsdetailed results COLCHIVID, 2021 0.69 [0.20; 2.40]
Lanzoni, 2021 0.11 [0.01; 0.93]
Lopes MIF, 2020 1.06 [0.02; 56.61]
Salehzadeh, 2020 1.00 [0.02; 51.41]
Shi, 2020 0.53 [0.01; 27.55]
0.48 [0.18 ; 1.28 ] COLCHIVID, 2021, Lanzoni, 2021, Lopes MIF, 2020, Salehzadeh, 2020, Shi, 2020 5 0% 385 low not evaluable deaths (time to event analysis only)detailed results Lanzoni, 2021 0.11 [0.01; 0.93]
0.11 [0.01 ; 0.93 ] Lanzoni, 2021 1 0% 24 NA not evaluable hospital dischargedetailed results COLCHIVID, 2021 1.13 [0.76; 1.67]
1.13 [0.76 ; 1.67 ] COLCHIVID, 2021 1 0% 126 NA not evaluable ICU admissiondetailed results Lopes MIF, 2020 1.06 [0.06; 18.45]
1.06 [0.06 ; 18.45 ] Lopes MIF, 2020 1 0% 35 NA not evaluable recoverydetailed results Lanzoni, 2021 3.46 [1.05; 11.35]
3.46 [1.05 ; 11.35 ] Lanzoni, 2021 1 0% 24 NA not evaluable serious adverse eventsdetailed results Lanzoni, 2021 0.10 [0.01; 0.69]
Shi, 2020 1.08 [0.04; 32.96]
0.21 [0.02 ; 1.86 ] Lanzoni, 2021, Shi, 2020 2 29% 124 moderate not evaluable adverse eventsdetailed results COLCHIVID, 2021 1.63 [0.67; 3.95]
Lanzoni, 2021 0.18 [0.02; 1.95]
Shi, 2020 0.88 [0.38; 2.03]
0.98 [0.43 ; 2.21 ] COLCHIVID, 2021, Lanzoni, 2021, Shi, 2020 3 38% 124 low not evaluable 0.0 5.0 1.0 relative treatment effect www.metaEvidence.org 2024-05-07 13:03 +02:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
pathologies: 95,94,90,91
- treatments: 564,944,682,1266,943,894,560,1102,598,563,668,753,752,836,639,541,534,581,615
- roots T: 290
